By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is that while SMH's concentration on NVIDIA and AI-driven stocks has led to recent outperformance, it also exposes investors to significant concentration risk. The panelists agree that the current valuations and AI demand may not be sustainable, and a downturn in the semiconductor cycle or regulatory hurdles could lead to substantial losses.
Risk: Concentration risk due to SMH's heavy weighting in NVIDIA and other AI-exposed mega-caps, which could lead to significant losses if the semiconductor cycle peaks or regulatory scrutiny hits NVIDIA.
Opportunity: SOXX's more balanced exposure to 31 names could offer better risk-adjusted returns in a semiconductors downturn.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
No pair dominated ETF.com's comparison tool in the first half of 2026 more than the VanEck Semiconductor ETF (SMH) against the iShares Semiconductor ETF (SOXX), with 6,743 views. With the AI infrastructure buildout continuing to fuel explosive demand for chips, it's little surprise investors want to know which semiconductor ETF belongs in their portfolio.
On the surface, these two funds look nearly identical — same sector, overlapping holdings, nearly identical expense ratios (SMH at 0.35%, SOXX at 0.34%). But dig into the details and meaningful differences emerge.
The biggest distinction is portfolio construction. SMH holds just 26 stocks, making it a highly concentrated bet on the sector's largest players. NVIDIA alone represents 17.55% of the fund. SOXX, by contrast, holds 31 names and applies a more equal-weight tilt — NVIDIA sits at just 6.81% there, while Micron Technology and AMD each carry larger weights than in SMH.
That difference in construction has translated into divergent performance. Over the trailing year through mid-2026, SOXX returned 169.68% compared to SMH's 135.91% — a stunning gap driven in part by SOXX's heavier exposure to names that outperformed. Over three years, however, SMH holds the edge, returning 63.44% against SOXX's 56.95% CAGR.
Size is also a factor: SMH is the larger fund at $74.4B in AUM versus SOXX's $45.9B, and SMH's average daily dollar volume of $6.1B gives it a slight liquidity advantage. For investors who want pure, high-octane semiconductor exposure in a liquid wrapper, this debate isn't going away anytime soon.
#2: SPY vs. IVV — The Classic Duel Investors Never Stop Running
It says something about investor behavior that the most fundamental ETF comparison in all of finance — SPDR S&P 500 ETF Trust (SPY) versus iShares Core S&P 500 ETF (IVV) — still generates nearly 5,000 organic comparison page views in a single half-year (4,783 to be exact). Both funds track the same index, hold the same 505 stocks, and deliver virtually identical performance.
So why do investors keep comparing them? Because the devil is in the details — specifically, costs and trading dynamics.
IVV charges just 0.03% annually, while SPY charges 0.09% — a three-times cost disadvantage for SPY that, compounded over years in a large position, becomes real money. IVV's trailing 12-month tracking difference of -0.03% also slightly outpaces SPY's -0.12%, suggesting it captures a touch more of the index's return in practice.
SPY fights back on liquidity. With $33.2B in average daily dollar volume, it dwarfs IVV's $3.3B — making it the preferred vehicle for institutional traders, options users, and anyone who needs to move large blocks quickly. For long-term buy-and-hold investors, IVV's lower fee profile is the clear winner. For active traders, SPY's unmatched liquidity often justifies the cost premium.
In 2026, both funds are tracking the S&P 500's year-to-date gain of roughly 10%, with one-year returns near 22%. Identical results, just different tools for different jobs.
#3: SCHG vs. QQQM — The Budget Growth Showdown
Rounding out the top three with 4,614 views is a pairing that captures one of the more interesting debates in growth investing: Schwab U.S. Large-Cap Growth ETF (SCHG) versus Invesco NASDAQ 100 ETF (QQQM). Both are popular, low-cost options for investors seeking growth exposure — but they tell very different stories.
SCHG is the fee champion at just 0.04%, compared to QQQM's 0.15%. It also offers a broader portfolio, holding 195 stocks against QQQM's 103, providing more diversification across sectors including finance and healthcare, which QQQM underweights or excludes.
QQQM, however, has the performance edge in the near term. It returned 34.08% over the trailing year versus SCHG's 16.33%, and 20.09% year-to-date versus SCHG's 3.97%. QQQM's heavier concentration in technology (nearly 45% of assets) has paid off in a market dominated by semiconductor and mega-cap tech gains.
The tradeoff is concentration versus breadth. QQQM's top 10 include names like Micron Technology (5.64%) and Intel (3.04%) — stocks that surged on AI tailwinds — giving it a more semiconductor-tilted complexion than SCHG. SCHG, with its Dow Jones U.S. Large-Cap Growth Index mandate, casts a wider net that includes more healthcare and financial names.
At $99.6B in AUM, QQQM has grown into a behemoth. SCHG ($58.4B) is no slouch either. But for cost-conscious investors who want the broadest possible large-cap growth exposure, SCHG's 0.04% expense ratio is difficult to ignore — even if QQQM has recently earned its keep.
Data sourced from ETF.com as of July 2, 2026. Past performance is not indicative of future results. This article is for informational purposes only and does not constitute investment advice.
Want to run your own comparisons? Use the ETF.com ETF Comparison Tool to analyze any two ETFs side by side across performance, costs, holdings, and more.
This article was generated with the assistance of artificial intelligence and reviewed by ETF.com staff.
Investment Risk Disclosure The information provided on this website is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Nothing on this site should be construed as a recommendation to buy, sell, or hold any security or financial product. General Investment Risks Investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. The value of investments may fluctuate, and investors may receive back less than they originally invested. There is no guarantee that any investment strategy will achieve its objectives. ETF-Specific Risks Exchange-traded funds (ETFs) are subject to risks similar to those of stocks and other equity securities. ETF shares are bought and sold at market price, which may differ from the fund's net asset value (NAV). Brokerage commissions may apply and will reduce returns. ETFs may be subject to the following additional risks:
Market Risk: The value of an ETF may decline due to broad market fluctuations unrelated to the underlying securities. Liquidity Risk: Some ETFs may have limited trading volume, which could make it difficult to buy or sell shares at a desired price. Tracking Error Risk: An ETF may not perfectly replicate the performance of its benchmark index. Concentration Risk: Sector or thematic ETFs may be concentrated in a particular industry or geography, increasing volatility. Currency Risk: ETFs that invest in international securities may be affected by exchange rate fluctuations. Leverage and Inverse Risk: Leveraged and inverse ETFs are designed for short-term trading and may not be suitable for long-term investors. These products use derivatives and may experience significant losses.
No Warranty While efforts are made to ensure the accuracy of information presented, no warranties are made regarding completeness, accuracy, or timeliness. Information may change without notice. Not a Fiduciary This site does not act as a fiduciary on behalf of any user. Users are encouraged to consult with a registered investment advisor, financial planner, or other qualified professional before making any investment decisions.
Four leading AI models discuss this article
"Historical performance gaps between SMH and SOXX are unlikely to persist without continued equal-weight leadership that the article does not substantiate."
The article frames surging comparison traffic for SMH/SOXX as evidence of sustained AI-driven semiconductor demand, yet this overlooks that SOXX's 169.68% trailing-year edge over SMH stemmed from temporary equal-weight tilts to Micron and AMD that may not repeat. Liquidity and fee differentials between SPY/IVV and SCHG/QQQM are real but investor-specific; long-term holders ignoring IVV's 0.06% expense advantage or SCHG's 0.04% fee risk compounding shortfalls. Missing context includes forward valuations, potential capex digestion by hyperscalers, and whether 2026's 10% YTD S&P gain persists amid rate uncertainty. Concentration in 26-name SMH amplifies single-stock shocks like NVIDIA drawdowns.
If AI infrastructure spending accelerates beyond current forecasts, SOXX's recent outperformance could extend rather than revert, rendering concentration and fee concerns secondary to capture of upside.
"The high correlation between concentrated semiconductor ETFs and mega-cap tech indices suggests that investors are underestimating their systemic exposure to a single, over-extended growth theme."
The obsession with these ETF pairs reveals a dangerous complacency regarding concentration risk. Investors are treating SMH and QQQM as 'set-it-and-forget-it' vehicles, ignoring that these funds are essentially leveraged bets on a narrow cohort of AI-exposed mega-caps. While the article highlights liquidity and expense ratios, it misses the systemic risk: if the semiconductor cycle peaks or regulatory scrutiny hits NVIDIA, these ETFs will move in lockstep, offering zero diversification benefit. The preference for SPY over IVV by institutional traders confirms that cost-efficiency is being sacrificed for the ability to exit positions rapidly—a clear sign that smart money is preparing for volatility.
The concentration in these ETFs is not a bug but a feature; by design, they provide surgical exposure to the most productive capital-intensive sector in the global economy, which has historically rewarded such high-conviction allocation.
"The article conflates recent outperformance with structural superiority while ignoring that both funds are leveraged bets on AI capex sustainability at historically stretched valuations."
This article is essentially a product comparison dressed as market analysis — useful for ETF selection but dangerously silent on the elephant in the room: semiconductor valuations in mid-2026. SMH's 17.55% NVIDIA weighting at what we must assume is an inflated AI-bubble valuation creates concentration risk the article treats as a feature, not a bug. SOXX's outperformance (169.68% vs 135.91% trailing) is framed as construction superiority, but equal-weighting mid-tier chip names (Micron, AMD) during an AI buildout cycle may simply be riding coattails. Neither fund addresses whether 2026 chip multiples are sustainable post-capex cycle.
If AI infrastructure demand genuinely persists through 2027-28 and semiconductor supply remains constrained, SMH's NVIDIA concentration is exactly where you want to be — the article's performance gap supports this thesis, not contradicts it.
"SMH’s Nvidia concentration creates meaningful downside risk relative to SOXX should AI demand weaken or Nvidia face headwinds, potentially outweighing SMH’s recent outperformance."
The article frames SMH vs. SOXX as a pure construction choice driven by concentration versus breadth, with AI tails driving recent outperformance for SMH’s Nvidia-heavy tilt. My view: the strongest counterweight is risk concentration. SMH’s 17.55% Nvidia weight (vs 6.81% in SOXX) creates asymmetric downside risk if AI demand cools, a cycle inflects, or regulatory hurdles land on key names. SOXX’s 31-name, more balanced exposure could offer better risk-adjusted returns in a semis downturn, even if it underwhelms in a hot AI rally. The piece also relies on trailing performance, which can revert; proper context requires cycle-wide multiples, capex rhythms, and macro risk.
If the AI cycle persists longer and Nvidia-driven gains stay durable, SMH could extend its lead and outperform SOXX on a risk-adjusted basis; the diversification of SOXX may not compensate for a long-tailed AI regime, making the contrast less advantageous for SMH holders. The strongest counterpoint to my stance is that concentration can become a source of persistent alpha if the cycle remains unusually favorable.
"SPY dominance reflects derivatives hedging tools, not imminent ETF exits amid AI concentration."
Gemini's read of SPY preference as smart-money exit prep overlooks that SPY's edge comes from unmatched options depth and futures integration, letting institutions delta-hedge NVIDIA-heavy exposures without selling the ETF. This directly ties into the concentration risks Claude and ChatGPT highlight, implying sophisticated players expect to manage single-name shocks inside the wrapper rather than flee it. Yet this assumes derivatives stay liquid when semis actually crack.
"Institutional reliance on derivatives to hedge concentration risk creates a false sense of security that will exacerbate volatility when liquidity eventually dries up."
Grok, your point on SPY options depth is crucial, but it ignores the second-order effect: if institutions are delta-hedging NVIDIA-heavy ETFs via derivatives, they are effectively creating a synthetic floor that masks underlying volatility until it inevitably breaks. When that liquidity evaporates during a true sector correction, the 'smart money' exit strategy fails. We aren't just looking at concentration risk; we are looking at a fragile, derivative-dependent structure that amplifies systemic tail risk.
"Concentration risk in SMH is overstated relative to cycle risk shared across all semiconductor ETFs."
Gemini's synthetic-floor thesis assumes derivatives liquidity evaporates uniformly, but SMH's 26-name construction actually *reduces* single-name tail risk versus SOXX's 31-name equal-weight. If NVIDIA corrects 40%, SMH bleeds ~7%; SOXX's Micron/AMD equal-weights may crater harder if capex cycles diverge. The real fragility isn't concentration—it's that *all four funds* are correlated bets on the same capex cycle. Hedging one doesn't solve sector-wide drawdown.
"SMH's concentration does not meaningfully reduce tail risk; Nvidia-led AI cycle downturn can drag multiple holdings and the broader semis complex."
Claude's line that SMH reduces single-name tail risk feels overstated. Even with 26 names, SMH's payoff leans heavily on Nvidia and the AI capex cycle; a Nvidia-led correction or broader AI slowdown would pull multiple holdings down through knock-on demand. Concentration isn't the antidote; it's a lever for idiosyncratic shocks to ripple across semis. The real tail risk: synchronized cyclical downturn and regulatory headwinds.
The panel consensus is that while SMH's concentration on NVIDIA and AI-driven stocks has led to recent outperformance, it also exposes investors to significant concentration risk. The panelists agree that the current valuations and AI demand may not be sustainable, and a downturn in the semiconductor cycle or regulatory hurdles could lead to substantial losses.
SOXX's more balanced exposure to 31 names could offer better risk-adjusted returns in a semiconductors downturn.
Concentration risk due to SMH's heavy weighting in NVIDIA and other AI-exposed mega-caps, which could lead to significant losses if the semiconductor cycle peaks or regulatory scrutiny hits NVIDIA.